News for hackers. Stuff that matters.
Re:Anti-addiction drug maker found a captive market in the c... by rocqua on Friday June 30, 2017 @08:18PM (#14674444)
I'd say that on-scene pain management is a luxury compared to fixing an opioid addiction. (Maybe the desensitization makes pain management harder anyway).

A drug addict seems more likely to suffer from his addiction than to suffer from an accident. I am basing this on the assumption that naltrexone will only delay pain treatment by a day at most. If it has people in agonizing pain until it wears off things are different.

There are no comments on this comment yet.